Rocuronium-induced neuromuscular block and sugammadex in pediatric patient with duchenne muscular dystrophy A case Report
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Ji Eun | - |
dc.contributor.author | Chun, Hea Rim | - |
dc.date.accessioned | 2021-08-11T15:24:11Z | - |
dc.date.available | 2021-08-11T15:24:11Z | - |
dc.date.issued | 2017-03 | - |
dc.identifier.issn | 0025-7974 | - |
dc.identifier.issn | 1536-5964 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/7721 | - |
dc.description.abstract | Introduction: Anesthetic management of patients with Duchenne muscular dystrophy (DMD) is complicated because these patients are more sensitive to nondepolarizing neuromuscular blocking agents (NMBAs) and are vulnerable to postoperative complications, such as postoperative residual curarization and respiratory failure. Sugammadex is a new reversal agent for aminosteroidal NMBAs, but its safety in children is controversial. Clinical features: An 11-year-old boy with DMD underwent general anesthesia for a percutaneous nephrolithotomy. We used rocuronium bromide and sugammadex to reverse the deep neuromuscular block. Reversal of neuromuscular block was done 15 minutes after administration of 2mg/kg of sugammadex. The patient's recovery from anesthesia was uneventful, and he was discharged to the postoperative recovery ward. Conclusion: A delayed recovery was achieved, but no adverse events were observed, such as recurarization or hypersensitivity to sugammadex. We report safe use of 2mg/kg of sugammadex to reverse a deep neuromuscular block in a child with DMD. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Lippincott Williams & Wilkins Ltd. | - |
dc.title | Rocuronium-induced neuromuscular block and sugammadex in pediatric patient with duchenne muscular dystrophy A case Report | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1097/MD.0000000000006456 | - |
dc.identifier.scopusid | 2-s2.0-85016923702 | - |
dc.identifier.wosid | 000398606800024 | - |
dc.identifier.bibliographicCitation | Medicine, v.96, no.13 | - |
dc.citation.title | Medicine | - |
dc.citation.volume | 96 | - |
dc.citation.number | 13 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | REVERSAL | - |
dc.subject.keywordPlus | VECURONIUM | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordAuthor | duchenne muscular dystrophy | - |
dc.subject.keywordAuthor | neuromuscular blocking agents | - |
dc.subject.keywordAuthor | pediatrics | - |
dc.subject.keywordAuthor | sugammadex | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.